Ultrasound pressure test to predict treatment response in liver metastases
Part of Cancer, Digestive system clinical trials.
This study tests a new ultrasound technique to see if it can predict early how well your cancer treatment will work on liver tumors that started in the colon or rectum. It uses special sound waves to measure pressure inside the tumor, which might help doctors adjust treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have colorectal cancer that has spread to the liver, and this is your first treatment for the liver tumors.
- The liver tumor is 6 cm or smaller and can be seen clearly on an ultrasound (usually not too deep).
- You are about to start standard first-line treatment (like chemotherapy or targeted therapy) for the cancer.
- You have not had any prior treatment for these liver tumors, including surgery, ablation, or other methods.
- You can lie flat for an ultrasound and have no allergy to the contrast agent used in the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special ultrasound technique to see if it can predict how well your stomach cancer that has spread to the liver will respond to the first treatment you receive. The goal is to help doctors choose the best treatment for you.
This trial uses a special ultrasound with a contrast agent to see how well a liver cancer treatment called TACE is working. It may help doctors better understand if the treatment is shrinking the tumor.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This trial tests a new ultrasound technique called SHAPE to see if it can detect high blood pressure in the liver (portal hypertension) without needing an invasive procedure. It may help people who are already scheduled for a standard liver pressure measurement.
This Phase 3 study tests a noninvasive ultrasound-based method to estimate portal hypertension, which is high blood pressure in the liver’s blood vessels. It aims to help doctors measure how severe the liver circulation problem is without needing invasive pressure testing.
Hear when a new Colorectal Liver Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.